Clinical evaluation of safety and efficacy of a plasma-derived factor VIII (CROSS EIGHT M) in previously untreated patients with hemophilia A

Akira YOSHIOKA, Akira SHIRAHATA, Katsuyuki FUKUTAKE, Tadashi KAMIYA, Michio FUJIMAKI

Open source

DOI
10.2491/jjsth.17.682
Published
2006
Container
Japanese Journal of Thrombosis and Hemostasis
Publisher
Japanese Society on Thrombosis and Hemostasis
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2491/jjsth.17.682,
  title = {Clinical evaluation of safety and efficacy of a plasma-derived factor VIII (CROSS EIGHT M) in previously untreated patients with hemophilia A},
  author = {Akira YOSHIOKA and Akira SHIRAHATA and Katsuyuki FUKUTAKE and Tadashi KAMIYA and Michio FUJIMAKI},
  year = {2006},
  journal = {Japanese Journal of Thrombosis and Hemostasis},
  doi = {10.2491/jjsth.17.682},
  url = {https://doi.org/10.2491/jjsth.17.682}
}

RIS

TY  - JOUR
TI  - Clinical evaluation of safety and efficacy of a plasma-derived factor VIII (CROSS EIGHT M) in previously untreated patients with hemophilia A
AU  - Akira YOSHIOKA
AU  - Akira SHIRAHATA
AU  - Katsuyuki FUKUTAKE
AU  - Tadashi KAMIYA
AU  - Michio FUJIMAKI
PY  - 2006
JO  - Japanese Journal of Thrombosis and Hemostasis
DO  - 10.2491/jjsth.17.682
UR  - https://doi.org/10.2491/jjsth.17.682
ER  - 

APA

YOSHIOKA, A., SHIRAHATA, A., FUKUTAKE, K., KAMIYA, T., & FUJIMAKI, M. (2006). Clinical evaluation of safety and efficacy of a plasma-derived factor VIII (CROSS EIGHT M) in previously untreated patients with hemophilia A. Japanese Journal of Thrombosis and Hemostasis. https://doi.org/10.2491/jjsth.17.682

Source records